GTR 76832867
Bids Are Invited For Registration Of Prices For The Acquisition Of Oncological Medications (Pharmacological Materials), To Be Used By The Hospital De Aeronáutica De Belém And Other Organizations Supported By Gapbe.
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
76832867
Tendering Authority
Subscribe to view
Tender No
100/2023
Financer Name
Self-Funded
Work Title
Bids Are Invited For Registration Of Prices For The Acquisition Of Oncological Medications (Pharmacological Materials), To Be Used By The Hospital De Aeronáutica De Belém And Other Organizations Supported By Gapbe.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
29-02-2024
Closed
Work Detail
Registration Of Prices For The Acquisition Of Oncological Medications (Pharmacological Materials), To Be Used By The Hospital De Aeronáutica De Belém And Other Organizations Supported By Gapbe.. Abiraterone Acetate,Zoledronic Acid,Aflibercept,Aflibercept,Epoetin Alfa,Epoetin Alfa,Anastrozole,Bevacizumab,Bevacizumab,Bicalutamide,Bortezomib,Capecitabine,Carboplatin,Cetuximab,Cyclophosphamide,Cyclophosphamide,Cisplatin,Denosumab,Docetaxel,Docetaxel,Do Xorrubicin Hydrochloride,Doxorubicin Hydrochloride,Enzalutamide, Epirubicin Hydrochloride, Etoposide, Filgrastim, Fluorouracil, Calcium Folinate, Fulvestrant, Gefitinib, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride, Hydroxyurea, Imatinib Mesylate, Imatinib Mesylate, Irinotecan Hydrochloride, Lenalidomide, Letrozole, Leuprorelin Acetate, Leuprorrhea Lina Acetate,Mesna,Methotrexate,Methotrexate, Nivolumab,Nivolumab,Octreotide,Octreotide,Octreotide,Olaparib,Oxaliplatin,Oxaliplatin,Paclitaxel,Pembrolizumab,Pemetrexed,Pertuzumab,Ranibizumab,Sorafenib Tosylate,Sunitinib,Sunitinib,Sunitinib,Tamoxifen Citrate,Temozolomide,Temozolomide,Temo Zolomide,Trastuzumab,Trastuzumab,Goserelin Acetate ,Goserelin Acetate,Aflibercept,Aflibercept,Epoetin Alpha,Bevacizumab,Bevacizumab,Cetuximab,Enzalutamide,Fluoruracil,Calcium Folinate,Lenalidomide,Leuprorelin Acetate,Nivolumab,Nivolumab,Octreotide,Octreotide,Olaparib,Paclitaxel,Pembrolizumab ,Pertuzumab,Ranibizumab,Sorafenib Tosylate, Sunitinib,Sunitinib,Sunitinib,Trastuzumab,Trastuzumab,Goserelin Acetate
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
a1ed0ffa-55e8-4715-bcb4-79e1b9ef55bf.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.